| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 49 |
| 1 | TACROLIMUS | 32 |
| 2 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 30 |
| 3 | TACROLIMUS OINTMENT 0.1% | 30 |
| 4 | PREDNISOLONE | 20 |
| 5 | PREDNISOLONE ORAL | 20 |
| 6 | PREDNISOLONE ORAL SOLUTION | 20 |
| 7 | DEXAMETHASONE | 19 |
| 8 | DEXAMETHASONE 1.5 MG | 19 |
| 9 | MYCOPHENOLATE MOFETIL | 19 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FLUCYTOSINE | 4 | 0.0028 |
| 1 | LIDOCAINE HCL 3% | 1 | 0.0022 |
| 2 | HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN | 1 | 0.0021 |
| 3 | THIOGUANINE | 2 | 0.0009 |
| 4 | CAFFEINE CITRATE | 2 | 0.0009 |
| 5 | VANCOMYCIN HYDROCHLORIDE | 7 | 0.0008 |
| 6 | CIDOFOVIR ANHYDROUS | 1 | 0.0007 |
| 7 | BELATACEPT | 3 | 0.0006 |
| 8 | PEGASPARGASE | 7 | 0.0006 |
| 9 | ATOVAQUONE | 4 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Nucleoside Analog Antifungal [EPC] | 4 | 0.0028 |
| 1 | Selective T Cell Costimulation Blocker [EPC] | 3 | 0.0006 |
| 2 | Asparagine-specific Enzyme [EPC] | 7 | 0.0005 |
| 3 | Antimetabolite Immunosuppressant [EPC] | 10 | 0.0005 |
| 4 | Isocitrate Dehydrogenase 1 Inhibitor [EPC] | 1 | 0.0005 |
| 5 | CCR5 Co-receptor Antagonist [EPC] | 1 | 0.0004 |
| 6 | Antimalarial [EPC] | 4 | 0.0004 |
| 7 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 5 | 0.0004 |
| 8 | Antiprotozoal [EPC] | 4 | 0.0004 |
| 9 | Echinocandin Antifungal [EPC] | 3 | 0.0004 |